What is Seer?
Founded in 2017, Seer operates within the life sciences sector, focusing on advanced proteomic analysis. The company's technology aims to unlock novel insights into biological processes and disease mechanisms by providing deep molecular understanding. This strategic focus positions Seer at the forefront of innovation in precision medicine and drug discovery, leveraging its proprietary platform to address complex challenges in healthcare.
How much funding has Seer raised?
Seer has raised a total of $479.5M across 7 funding rounds:
Series A
$6M
Series B
$36M
Series C
$17.5M
Series D
$55M
Multiple Rounds
$365M
Series A (2017): $6M with participation from Maverick Ventures
Series B (2018): $36M led by Maverick Ventures and Invus
Series C (2019): $17.5M supported by Invus, Wing Companies, Maverick Ventures, and AJU IB INVESTMENT
Series D (2019): $55M featuring aMoon
Other Financing Round (2020): $55M backed by HBM Healthcare Investments AG, Maverick Ventures, aMoon, Fidelity Investments Inc., T. Rowe Price Associates, and Invus
Share Placement (2020): $135M with participation from aMoon Fund, SoftBank, T. Rowe Price, and Fidelity
Stock Issuance/Offering (2020): $175M led by Undisclosed
Key Investors in Seer
HBM Healthcare Investments AG
HBM Healthcare Investments is a publicly traded investment company focused on the global healthcare sector, with a diversified portfolio of private and publicly listed companies. The firm aims to capitalize on the significant growth opportunities within the healthcare market, driven by demographic trends, medical advancements, and increasing demand for innovative therapies.
Maverick Ventures
Maverick Ventures Israel is a venture capital firm dedicated to supporting technology start-ups by providing investment and operational support. They focus on diverse industries, seeking exceptional teams with differentiated technology and initial traction. The firm offers capital investments typically ranging from $2-5 million, along with a network of experienced investors and operational guidance.
T. Rowe Price Associates
Founded in 1937, T.Rowe Price Group provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. The firm launches and manages equity and fixed income mutual funds and invests in the public equity and fixed income markets globally.
What's next for Seer?
The recent major strategic investment signals a strong vote of confidence in Seer's technology and market potential. This influx of capital is expected to fuel further research and development, scale its operational capabilities, and accelerate the commercialization of its proteomic insights platform. Seer is poised to expand its impact on the life sciences industry, potentially leading to new therapeutic strategies and diagnostic tools.
See full Seer company page
